glp-1 drugs and gallbladder FDA Data Link Diabetes Drug Class to Disease no gallbladder and glp 1
Description
Country Segmental Analysis 16.8.2
Ongoing guidance and monitoring to track progress and manage potential side effects
Abstract Diabetes mellitus, a condition that significantly elevates the incidence and mortality risks associated with cardiovascular diseases, exacerbates the disease burden in China
FDA-approved labeling governs the use of these medications
